Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F F Russ Knapp

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Radiopharmaceuticals|August 1, 2012
Radionuclide generators - a new renaissance in the development of technologies to provide diagnostic and therapeutic radioisotopes for clinical applicationsF F Russ Knapp, R P Baum
Seminars in Nuclear Medicine|February 5, 2008
Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapyJae Min Jeong, F F Russ Knapp
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|September 28, 2012
Molybdenum-99 production from reactor irradiation of molybdenum targets: a viable strategy for enhanced availability of technetium-99mM R A Pillai, F F Russ Knapp
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2011
Overcoming the 99mTc shortage: are options being overlooked?M R A Pillai, F F Russ Knapp
Current Radiopharmaceuticals|November 1, 2018
The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical ApplicationsValery Radchenko, Paul Schaffer, F F Russ Knapp
Current Radiopharmaceuticals|September 25, 2013
Targeted radionuclide therapy--an overviewAshutosh Dash, F F Russ Knapp, M R A Pillai
Nuclear Medicine and Biology|November 13, 2012
99Mo/(99m)Tc separation: an assessment of technology optionsAshutosh Dash, F F Russ Knapp, M R A Pillai
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 21, 2012
Sustained availability of 99mTc: possible paths forwardMaroor Raghavan Ambikalmajan Pillai, Ashutosh Dash, F F Russ Knapp
Chemical Reviews|April 14, 2015
Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applicationsSharmila Banerjee, M R A Pillai, F F Russ Knapp
Endocrinology|April 28, 2007
Ligand-activated peroxisome proliferator activated receptor gamma alters placental morphology and placental fatty acid uptake in miceW Timothy Schaiff, F F Russ Knapp, Yaacov Barak, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Radiopharmaceuticals|August 1, 2012
Radionuclide generators - a new renaissance in the development of technologies to provide diagnostic and therapeutic radioisotopes for clinical applicationsF F Russ Knapp, R P Baum
Seminars in Nuclear Medicine|February 5, 2008
Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapyJae Min Jeong, F F Russ Knapp
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|September 28, 2012
Molybdenum-99 production from reactor irradiation of molybdenum targets: a viable strategy for enhanced availability of technetium-99mM R A Pillai, F F Russ Knapp
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2011
Overcoming the 99mTc shortage: are options being overlooked?M R A Pillai, F F Russ Knapp
Current Radiopharmaceuticals|November 1, 2018
The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical ApplicationsValery Radchenko, Paul Schaffer, F F Russ Knapp
Current Radiopharmaceuticals|September 25, 2013
Targeted radionuclide therapy--an overviewAshutosh Dash, F F Russ Knapp, M R A Pillai
Nuclear Medicine and Biology|November 13, 2012
99Mo/(99m)Tc separation: an assessment of technology optionsAshutosh Dash, F F Russ Knapp, M R A Pillai
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 21, 2012
Sustained availability of 99mTc: possible paths forwardMaroor Raghavan Ambikalmajan Pillai, Ashutosh Dash, F F Russ Knapp
Chemical Reviews|April 14, 2015
Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applicationsSharmila Banerjee, M R A Pillai, F F Russ Knapp
Endocrinology|April 28, 2007
Ligand-activated peroxisome proliferator activated receptor gamma alters placental morphology and placental fatty acid uptake in miceW Timothy Schaiff, F F Russ Knapp, Yaacov Barak, et al.
Pageof 2